Jonathan Bixby and Mike Edwards, the duo that’s taken public companies involved in cryptocurrencies, e-sports and cannabis, are back with a fourth London listing in eight months. This time, it’s psychedelics.

Clarify Pharma invests in biotech and life-sciences companies seeking to prove the safety and efficacy of psychedelic-based substances. It raised 1.96 million pounds ($2.3 million) on the Aquis Stock Exchange, a small U.K. bourse. The stock opened at 2.77 pence, up 11% from the 2.50 pence listing price.

Marijuana’s regulatory headway for medicinal use in recent years has paved the way for a flurry of initial public offerings in the U.K. Dozens of startups are betting on a similar legal shift for psychedelic substances, which are being used to develop treatments for illnesses…



Read Full Article Here